- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Sa | Arvinas Inc.: Arvinas Presents Preclinical Data Supporting Mechanistic Synergies and Enhanced Antitumor Activity with the Combination of ARV-393 and Glofitamab at the 2025 American Society of Hematology Annual Meeting and Exposition | ||
| Sa | Bicara Therapeutics Inc.: Bicara Therapeutics' Preliminary Phase 1b Expansion Cohort Data Evaluating 750mg of Ficerafusp Alfa Weekly Plus Pembrolizumab Advances Pivotal Study Dose Selection on Track for First Quarter 2026 | ||
| Sa | Beam Therapeutics Reports Updated Data from BEACON Phase 1/2 Trial of ristoglogene autogetemcel (risto-cel) Highlighting Durable, Differentiated Profile in Sickle Cell Disease (SCD) at American Society of Hematology (ASH) Annual Meeting | ||
| Sa | Aptose Biosciences, Inc.: Aptose's Tuspetinib Triple Drug Therapy Featured at the 2025 ASH Annual Meeting; High Rate of Frontline Clinical Responses Continues Across AML Populations | ||
| Sa | Disc Medicine Inc: Disc Medicine Presents Positive Initial Data from RALLY-MF Phase 2 Trial in Patients with Myelofibrosis (MF) and Anemia at the 67th American Society of Hematology (ASH) Annual Meeting | ||
| Sa | ORIC Pharmaceuticals Presents Potential Best-in-Class Profile for Enozertinib with Robust Systemic and CNS Activity in 1L and 2L NSCLC Patients with EGFR Exon 20 Mutations at the ESMO Asia Congress 2025 | ||
| Sa | Webus International Limited Issues Clarification on Previous Announcement Related to Expedia Group | ||
| Fr | Colabor Group Inc.: Colabor Group Announces Resignation of Director | ||
| Fr | Clearmind Medicine Inc.: Clearmind Medicine Announces Receipt of Nasdaq Minimum Bid Price Notification | ||
| Fr | Skyharbour Resources Ltd: Skyharbour Closes $2.1 Million Private Placement of Flow-Through Shares | ||
| Fr | Parsons Corporation: Parsons Selected As Lead Designer For $441 Million I-70 Rocheport To Columbia Design-Build Project | ||
| Fr | ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | ||
| Fr | Fulcrum Therapeutics, Inc.: Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | ||
| Fr | Global Mofy AI Limited Announces US$4.8 Million Private Placement Financing | ||
| Fr | Omega Flex, Inc. Announces Regular Quarterly Dividend for the Fourth Quarter 2025 | ||
| Fr | Quanex Building Products Corporation: Quanex Building Products Declares Quarterly Dividend | ||
| Fr | Sunrise New Energy Co., Ltd: Sunrise Signs 5,000-Ton Anode Material Supply Contract With Pylontech, Expanding Into the European Residential Energy Storage Market | ||
| Fr | Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | ||
| Fr | Spyre Therapeutics, Inc.: Spyre Therapeutics Announces Grants of Inducement Awards | ||
| Fr | Taysha Gene Therapies, Inc.: Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | ||
| Fr | Hingham Institution for Savings: Hingham Savings Authorizes Stock Repurchase Program | ||
| Fr | Kymera Therapeutics, Inc.: Kymera Therapeutics to Announce KT-621 BroADen Phase 1b Atopic Dermatitis Trial Results on December 8, 2025 | ||
| Fr | NewAmsterdam Pharma Company N.V.: NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | ||
| Fr | Intellia Therapeutics, Inc.: Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | ||
| Fr | Parsons Corporation: Parsons Selected for $1B Sound Transit MATOC to Support Regional Transit Expansion |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .